Search research articles
Contact Us
Filters
Showing results (911-920 of 1,205) with videos related to
Page
of 121
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
November 22, 2011
aza-Flavanones as potent cross-species microRNA inhibitors that arrest cell cycle
Srivari Chandrasekhar, Sreerangam N C V L Pushpavalli, Srinivas Chatla, et al.
Neuroimage
|
June 9, 2012
Quantitative evaluation of MRI-based tracking of ferritin-labeled endogenous neural stem cell progeny in rodent brain
Greetje Vande Velde, Janaki Raman Rangarajan, Ruth Vreys, et al.
Journal of Gastroenterology and Hepatology
|
May 21, 2016
Chronic hepatitis C burden and care cascade in Australia in the era of interferon-based treatment
Behzad Hajarizadeh, Jason Grebely, Hamish McManus, et al.
Cell Biochemistry and Biophysics
|
July 20, 2024
Exploring Bioactive Compounds of Rauvolfia tetraphylla L. (RT) for 3CLprotease of SARS-CoV2: GC-MS Analysis and In-Silico Studies
Gnanasekaran Ramakrishnan, Koteswara Reddy Gujjula, Janaki Ramaiah Mekala, et al.
The Lancet Regional Health. Western Pacific
|
September 16, 2024
Trends in viral hepatitis liver-related morbidity and mortality in New South Wales, Australia
Shane Tillakeratne, Sallie-Anne Pearson, Maryam Alavi, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 2, 2017
Avathrin: a novel thrombin inhibitor derived from a multicopy precursor in the salivary glands of the ixodid tick, <i>Amblyomma variegatum</i>
Janaki Krishnamoorthy Iyer, Cho Yeow Koh, Maria Kazimirova, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
July 30, 2014
Bone mineral density over 96 weeks in adults failing first-line therapy randomized to raltegravir/lopinavir/ritonavir compared with standard second-line therapy
Hila Haskelberg, Patrick W G Mallon, Jennifer Hoy, et al.
AIDS (London, England)
|
March 3, 2015
Early antiretroviral therapy with raltegravir generates sustained reductions in HIV reservoirs but not lower T-cell activation levels
William J Hey-Cunningham, John M Murray, Ven Natarajan, et al.
Drug and Alcohol Review
|
May 31, 2023
Factors associated with hepatitis C treatment uptake among females of childbearing age in New South Wales, Australia: A population-based study
Heather Valerio, Maryam Alavi, Alison D Marshall, et al.
The Medical Journal of Australia
|
June 9, 2012
Hepatitis C treatment outcomes in Australian clinics
Heather F Gidding, Matthew G Law, Janaki Amin, et al.
Page
of 121
Search research articles
Search
Showing results (911-920 of 1,205) with videos related to
Sort By:
Page
of 121
Bioorganic & Medicinal Chemistry Letters
|
November 22, 2011
aza-Flavanones as potent cross-species microRNA inhibitors that arrest cell cycle
Srivari Chandrasekhar, Sreerangam N C V L Pushpavalli, Srinivas Chatla, et al.
Neuroimage
|
June 9, 2012
Quantitative evaluation of MRI-based tracking of ferritin-labeled endogenous neural stem cell progeny in rodent brain
Greetje Vande Velde, Janaki Raman Rangarajan, Ruth Vreys, et al.
Journal of Gastroenterology and Hepatology
|
May 21, 2016
Chronic hepatitis C burden and care cascade in Australia in the era of interferon-based treatment
Behzad Hajarizadeh, Jason Grebely, Hamish McManus, et al.
Cell Biochemistry and Biophysics
|
July 20, 2024
Exploring Bioactive Compounds of Rauvolfia tetraphylla L. (RT) for 3CLprotease of SARS-CoV2: GC-MS Analysis and In-Silico Studies
Gnanasekaran Ramakrishnan, Koteswara Reddy Gujjula, Janaki Ramaiah Mekala, et al.
The Lancet Regional Health. Western Pacific
|
September 16, 2024
Trends in viral hepatitis liver-related morbidity and mortality in New South Wales, Australia
Shane Tillakeratne, Sallie-Anne Pearson, Maryam Alavi, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 2, 2017
Avathrin: a novel thrombin inhibitor derived from a multicopy precursor in the salivary glands of the ixodid tick, <i>Amblyomma variegatum</i>
Janaki Krishnamoorthy Iyer, Cho Yeow Koh, Maria Kazimirova, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
July 30, 2014
Bone mineral density over 96 weeks in adults failing first-line therapy randomized to raltegravir/lopinavir/ritonavir compared with standard second-line therapy
Hila Haskelberg, Patrick W G Mallon, Jennifer Hoy, et al.
AIDS (London, England)
|
March 3, 2015
Early antiretroviral therapy with raltegravir generates sustained reductions in HIV reservoirs but not lower T-cell activation levels
William J Hey-Cunningham, John M Murray, Ven Natarajan, et al.
Drug and Alcohol Review
|
May 31, 2023
Factors associated with hepatitis C treatment uptake among females of childbearing age in New South Wales, Australia: A population-based study
Heather Valerio, Maryam Alavi, Alison D Marshall, et al.
The Medical Journal of Australia
|
June 9, 2012
Hepatitis C treatment outcomes in Australian clinics
Heather F Gidding, Matthew G Law, Janaki Amin, et al.
Page
of 121